Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Cystic Fibrosis
  • Cystic Fibrosis Gastrointestinal Disease
  • Cystic Fibrosis in Children
Type
Observational
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Between 10 years and 125 years
Gender
Both males and females

Description

The aim is to determine the prevalence of intestinal inflammation by measurement of fecal calprotectin and/or histological evaluation of intestinal tissue biopsies in both pediatric and adult CF populations. Pediatric CF population (Age 10-18 years): Determine the prevalence of intestinal inflammati...

The aim is to determine the prevalence of intestinal inflammation by measurement of fecal calprotectin and/or histological evaluation of intestinal tissue biopsies in both pediatric and adult CF populations. Pediatric CF population (Age 10-18 years): Determine the prevalence of intestinal inflammation in a cohort of pediatric CF patients based on fecal calprotectin levels in stool samples. Assess the correlation between fecal calprotectin and abdominal symptoms/QOL. Adult CF population (Age ? 18 years): Determine the prevalence of intestinal inflammation in a cohort of adult CF patients based on histological evaluation of intestinal tissues biopsies and fecal calprotectin levels in stool samples in adult CF patients who have not undergone lung or liver transplantation. in adult CF patients who have undergone lung or liver transplantation. Assess the correlation between fecal calprotectin and histological-proven intestinal inflammation in adult CF patients. Assess the correlation between histological-proven intestinal inflammation and abdominal symptoms/QOL as well as the correlation between fecal calprotectin and abdominal symptoms/QOL.

Tracking Information

NCT #
NCT04392544
Collaborators
Cystic Fibrosis Canada
Investigators
Principal Investigator: Tanja Gonska, MD The Hospital for Sick Children